SCHEMBL6167233

SCHEMBL6167233

CC1(C)CCC(=O)c2c(Cc3ccccc3)nn(-c3ccc(Cl)nn3)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.39
CCNA2 P20248 1/20 0.39
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 3/20 0.35
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
HPGD P15428 2/20 0.34
ALPL P05186 1/20 0.34
CYP3A4 P08684 1/20 0.34
LMNA P02545 1/20 0.34
KDM4E B2RXH2 1/20 0.34
VEGFA P15692 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
CCNB2 O95067 1/20 0.31
CCNE2 O96020 1/20 0.31
CDK1 P06493 1/20 0.31
CDK4 P11802 1/20 0.31
CCNB1 P14635 1/20 0.31
CCND1 P24385 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167448 0.85 CYP1A2 (0.39) CDK2CCNA2RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6163693 0.84 RAB9A (0.41) CDK2CCNA2RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6164787 0.79 CCNA2 (0.39) CDK2CCNA2RAB9ASMN1; SMN2
SCHEMBL6164575 0.75 CCNA2 (0.38) CDK2CCNA2RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6166604 0.73 CCNA2 (0.39) CDK2CCNA2RAB9ASMN1; SMN2KDM4E
SCHEMBL6164821 0.69 CYP1A2 (0.43) CDK2CCNA2RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6167555 0.63 CCNA2 (0.39) CDK2CCNA2RAB9ASMN1; SMN2
SCHEMBL6166839 0.63 ALDH1A1 (0.50) CDK2CCNA2RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6166942 0.62 HTT (0.43) CDK2CCNA2RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6164846 0.61 CCNA2 (0.38) CDK2CCNA2RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed